Novel Antimicrobial Discovery Strengthens Intellectual Property Portfolio
T3Bioscience (T3), a United States-based agricultural biotechnology company focused on developing innovative microbial solutions for crop protection, has announced a significant expansion of its intellectual property portfolio with the issuance of its first international patent. The newly granted patent in Taiwan covers the company’s flagship product, RejuAgro, marking an important milestone in T3’s strategy to bring next-generation biological crop protection technologies to global agricultural markets.
The patent represents the first intellectual property protection granted to T3 outside the United States and underscores the growing international recognition of the company’s proprietary technology platform. RejuAgro, a nature-derived antimicrobial solution, has been developed to help growers combat a wide range of bacterial and fungal crop diseases while also supporting plant resilience against environmental stresses that increasingly threaten agricultural productivity.
As global agriculture faces mounting challenges from pathogen resistance, climate-related stressors, and increasing demands for sustainable food production, T3 believes its technology offers a promising alternative to traditional chemical crop protection products. The company’s latest patent achievement strengthens its position in the rapidly evolving biologicals sector and supports its broader mission of transforming crop protection through innovative, environmentally responsible solutions.
Addressing a Growing Need for New Crop Protection Technologies
The agricultural industry is facing increasing pressure to find effective alternatives to conventional synthetic pesticides and antimicrobial products. Over time, many plant pathogens have developed resistance to commonly used chemical treatments, reducing their effectiveness and creating significant challenges for farmers worldwide.
At the same time, concerns about antimicrobial resistance (AMR) have become a major global issue. The World Health Organization has identified AMR as one of the most serious threats to public health and sustainable development. While the issue is often associated with human and animal health, resistance also poses substantial risks in agriculture, where disease outbreaks can devastate crops and reduce food production.
Against this backdrop, T3Bioscience has focused its efforts on discovering and commercializing novel biological compounds that offer new modes of action. Such innovations are critical because they provide growers with tools that pathogens have not previously encountered, reducing the likelihood of resistance development while improving disease control.
RejuAgro represents one of the company’s most promising innovations. The product is based on a natural metabolite produced by selected Pseudomonas species and has demonstrated unique antimicrobial properties against important agricultural pathogens.
Unlike many existing crop protection products, RejuAgro employs an entirely new mode of action. This novel mechanism enables the product to deliver strong disease-control performance while maintaining exceptional stability under field conditions. According to the company, the combination of efficacy, stability, and environmental compatibility positions RejuAgro as a potentially transformative tool for modern agriculture.
Powered by the PROMISA Discovery Platform
The development of RejuAgro is closely tied to T3’s proprietary discovery platform known as PROMISA. The technology was developed under the leadership of Dr. Ching-Hong Yang, Distinguished Professor at the University of Wisconsin-Milwaukee (UWM), who has played a central role in advancing the company’s research and innovation efforts.
According to Yang, RejuAgro serves not only as a commercial product but also as a validation of the PROMISA platform’s ability to identify and develop novel microbial compounds with agricultural applications.
PROMISA combines advanced extraction, screening, and discovery technologies designed to identify naturally occurring metabolites with unique biological activity. The platform was developed over several years and represents a key component of T3’s long-term innovation strategy.
Yang explained that the success of RejuAgro demonstrates the effectiveness of the company’s approach and provides confidence that additional products can be generated from the same discovery engine in the future. As T3 continues to expand its research pipeline, PROMISA is expected to play a crucial role in identifying new solutions for crop protection, plant health, and agricultural sustainability.
Strong Performance Demonstrated in Independent Trials
T3 reports that independent field trials have consistently demonstrated the effectiveness of RejuAgro across multiple crop systems. According to the company, the product has delivered plant growth and yield outcomes comparable to those achieved with conventional agrochemical solutions.
One of RejuAgro’s most notable characteristics is its dual functionality. The product provides both curative and protective benefits, enabling growers to address existing disease pressure while also helping prevent future infections. This combination is particularly valuable in commercial agriculture, where disease outbreaks can rapidly spread and cause substantial economic losses.
The company believes that RejuAgro’s novel mode of action offers an additional advantage by helping farmers manage diseases that may no longer respond effectively to traditional treatments. By introducing a new biological mechanism into crop protection programs, growers can diversify their disease management strategies and reduce dependence on older chemistries.
Beyond disease control, the product has also been designed with sustainability in mind. As a nature-derived solution, RejuAgro aligns with growing market demand for agricultural inputs that minimize environmental impact while maintaining high levels of performance.
Initial Focus on High-Value Crops
T3Bioscience has identified several high-value crops and disease targets for the initial commercialization of RejuAgro. The company’s first priorities include apple production, where the product is being positioned to help manage destructive diseases such as fire blight and apple scab.
In citrus production, RejuAgro is being evaluated for its potential role in addressing Huanglongbing (HLB), also known as citrus greening disease, as well as citrus canker. These diseases have caused severe economic damage to citrus industries around the world and continue to represent major challenges for growers.
Additional target markets include walnuts, grapes, and strawberries, where important bacterial and fungal diseases continue to threaten productivity and profitability.
As part of the regulatory pathway toward commercialization, T3 completed all Environmental Protection Agency (EPA)-required environmental toxicity studies for RejuAgro in late 2025. The company is currently preparing the necessary documentation for submission to the EPA, an important step toward securing regulatory approval and market access in the United States.
Expanding the Pipeline Beyond Crop Protection
While RejuAgro remains the company’s lead product candidate, T3 is already advancing additional technologies through its development pipeline.
The next major product expected from the company is RejuPrime, a plant biostimulant built on the same core technology platform that produced RejuAgro. Unlike traditional crop protection products, RejuPrime is designed to enhance plant growth and productivity under challenging environmental conditions.
The product targets abiotic stresses such as drought and salinity, two of the most significant factors limiting agricultural yields globally. By helping plants maintain growth and performance under stress, RejuPrime could provide growers with a valuable tool for adapting to increasingly unpredictable climate conditions.
Together, RejuAgro and RejuPrime highlight T3Bioscience’s broader vision of leveraging microbial science to create innovative agricultural solutions that improve crop health, enhance productivity, and support long-term sustainability. As the company continues to secure international patent protection and advance its regulatory and commercialization efforts, it is positioning itself as an emerging player in the rapidly growing agricultural biologicals market.
Source Link:https://www.businesswire.com/
